期刊文献+

^18F-氟脱氧胸苷正电子发射体层显像应用及指导生物靶区勾划的展望 被引量:12

原文传递
导出
摘要 ^18F-氟脱氧葡萄糖(^18F-FDG,以下简称FDG)正电子发射体层显像(PET)或PET-CT为肿瘤诊断和放疗靶区勾划提供了重要依据。FDG作为肿瘤代谢显像剂已得到广泛的认可和应用,但其诊断肿瘤的特异性存在一定不足,会产生部分假阳性结果。^18F-氟脱氧胸苷(^18F-FLT,以下简称FLT)是胸腺嘧啶的类似物,能间接反映细胞DNA合成,
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第1期1-4,共4页 Chinese Journal of Oncology
关键词 影像诊断 功能影像 放射治疗 生物靶区 Diagnostic imaging Functional imaging Radiotherapy Biological target volume
  • 相关文献

参考文献21

  • 1Boothman DA, Davis TW, Sahijdak WM. Enhanced expression of thymidine kinase in human cells following ionizing radiation. Int J Radiat Oncol Biol Phys, 1994, 30:391-398.
  • 2Sundseth R, Joyner SS, Moore JT, et al. The anti-human-immunodeficiency vires agent 3 '-fluorothymidine induces DNA damage and apoptosis in human lymphoblastoid ceils. Antimicrob Agents Chemother, 1996, 40:331-335.
  • 3Been LB, Suurmeijer AJ, Cobben DC, et al. 18F-FLT PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging, 2004, 31:1659-1672.
  • 4Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with 18F-FLT and positron emission tomography. Nat Med, 1998, 4 : 1334-1336.
  • 5Rasey JS, Grierson JR, Wiens LW, et al. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med, 2002, 43 : 1210-1217.
  • 6Barthel H, Cleij MC, Collingridge DR, et al. 3'-deoxy-3'-18Ffluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.Cancer Res, 2003, 63:3791-3798.
  • 7Vesselle H, Grierson J, Muzi M, et al. In vivo validation of 3' deoxy-3 ,_18 F-fluorothymidine ( 18F-FLT) as a proliferation imaging tracer in humans: correlation of lS F-FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clin Cancer Res, 2002, 8: 3315-3323.
  • 8杨文锋,付政,于金明,王绍平,房玉芳,袁方,穆殿斌.^(18)F-FDG PET/CT对非小细胞肺癌区域淋巴结诊断的假阴性与假阳性研究[J].中华核医学杂志,2007,27(3):139-142. 被引量:12
  • 9Guo H, Zhu H, Xi Y, et al. Diagnostic and prognostic value of 18F-FDG PET-CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus. J Nucl Med, 2007, 48 : 1251-1258.
  • 10刘素文,于金明,邢力刚.^(18)F-FDG PET显像在非小细胞肺癌临床分期中的价值[J].中华肿瘤杂志,2004,26(10):626-629. 被引量:18

二级参考文献22

  • 1于金明,邢力刚,杨国仁.^(18)F-脱氧葡萄糖PET用于制定肿瘤放射治疗计划研究进展[J].中华放射肿瘤学杂志,2004,13(2):133-136. 被引量:20
  • 2陈盛祖.PET/CT的若干技术问题[J].中华核医学杂志,2005,25(2):72-74. 被引量:12
  • 3王学涛,于金明,杨国仁,巩合义.PET-CT同机融合精度验证及在放疗靶区勾画中的应用[J].中华放射肿瘤学杂志,2005,14(3):204-207. 被引量:13
  • 4杨文锋,于金明,李道堂.FDG PET显像对非小细胞肺癌纵隔淋巴结转移的检测[J].中华核医学杂志,2006,26(2):120-122. 被引量:9
  • 5Eloubeidi MA,Desmond R,Arguedas MR,et al.Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.:the importance of tumor length and lymph node status.Cancer,2002,95:1434-1443.
  • 6Choi JY,Jang HJ,Shim YM,et al.18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery:prognostic implications.J Nucl Med,2004,45:1843-1850.
  • 7Drudi FM,Trippa F,Cascone F,et al.Esophagogram and CT vs endoscopic and surgical specimens in the diagnosis of esophageal carcinoma.Radiol Med,2002,103:344-352.
  • 8Sachelarie I,Kerr K,Ghesani M,et al.Related Integrated PETCT:evidence-based review of oncology indications.Oncology,2005,19:481-492,495-496.
  • 9Konski A,Doss M,Milestone B,et al.The integration of 18-fluorodeoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma.Int J Radiat Oncol Biol Phys,2005,61:1123-1128.
  • 10Czemin J, Weber W. Translational molecular imaging. Mol Imaging Biol, 2004, 6: 181-182.

共引文献151

同被引文献142

引证文献12

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部